Please assess the completion status of the following clinical trial:

Trial Title: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed ICF (Informed Consent Form) and HIPAA (Health Insurance Portability and Accountability Act)~* Patient-reported history of DED in both eyes~* Current use of OTC (over-the-counter) and/or artificial tears for dry eye symptoms~* Ability and willingness to follow instructions, including participation in all study assessments and visits~Exclusion Criteria:~* Women who are pregnant, nursing or planning a pregnancy~* Unwillingness to submit a urine pregnancy test at screening and the last visit (or early termination visit) if of childbearing potential, or unwillingness to use acceptable means of birth control~* Clinically significant slit-lamp findings or abnormal lid anatomy at screening~* Ocular/periocular malignancy~* History of herpetic keratitis~* Active ocular allergies or ocular allergies that may become active during the study period~* Ongoing ocular or systemic infection at screening or baseline~* Wear of contact lenses within 3 months prior to screening or anticipated use of contact lenses during the study~* History of no response to previous topical Cyclosporine A and/or use of topical Cyclosporine A or Liftigrast within 2 months prior to screening~* Intraocular surgery or ocular laser surgery within the previous 6 months, or have any planned ocular and/or lid surgeries over the study period~* Presence of uncontrolled systemic diseases~* Presence of known allergy and/or sensitivity to the study drug or its components

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CyclASol Ophthalmic Solution (Type: EXPERIMENTAL): Cylclosporine A solution in vehicle
- Vehicle Ophthalmic Solution (Type: PLACEBO_COMPARATOR): Vehicle only

Based on this trial design, predict the completion outcome and termination type (if applicable).